Spirometra IgM ELISA Kit

The Spirometra IgM ELISA Kit is a qualitative enzyme-linked immunosorbent assay (ELISA) designed to detect IgM antibodies to Spirometra species in human serum samples. It is intended for early diagnosis of sparganosis and must be used by trained medical technologists.

Spirometra is a parasitic worm that completes its lifecycle in dogs and cats as definitive hosts. Humans acquire sparganosis as paratenic or secondary intermediate hosts through drinking water containing infected copepods or consuming undercooked intermediate host meat (e.g., snake or frog). Once infected, larvae can migrate to various locations, including subcutaneous tissue, pleural cavity, lungs, urinary tract, and the central nervous system, where they can survive for up to 20 years.

Clinical manifestations of sparganosis depend on the parasite's location. While subcutaneous infections are usually painless, migration to the central nervous system can result in neurological symptoms such as headaches, seizures, weakness, and numbness. Inner ear involvement may lead to vertigo or hearing loss. This kit uses recombinant Spirometra cysteine protease antigen-coated microplates to detect IgM antibodies, providing reliable diagnostic results through visual or ELISA reader interpretation.

Spirometra IgM ELISA Kit

√  Early Diagnosis: Detects acute infections via IgM antibody detection.

√  High Sensitivity: Achieves 100% sensitivity for accurate detection.

√  High Specificity: 98% specificity reduces false-positive results.

√  User-Friendly: Simplified protocol ensures quick and efficient testing.

√  Clear Results: Strong colorimetric reaction for visual or instrumental interpretation.

√  Stable Storage: Reagents remain stable at 2-8°C for long-term reliability.

√  Quality Assurance: Positive and negative controls included for consistent results.

√  Global Applicability: Meets international standards for diverse laboratory settings.

Spirometra IgM ELISA Kit

√  Clinical Laboratories: Early screening and diagnosis of sparganosis infections.

√  Public Health Centers: Epidemiological studies and health screenings in endemic regions.

√  Parasitology Research Institutions: Supporting studies on sparganosis immunology and pathology.

√  Food Safety and Hygiene Agencies: Evaluating risks of parasite transmission in the food chain.

√  Remote Healthcare Facilities: Providing reliable diagnostic tools for underserved areas.

√  International Quarantine Services: Screening travelers from endemic regions.

√  Community Health Projects: Promoting prevention and control measures in high-risk areas.

√  Education and Outreach Programs: Raising awareness about sparganosis prevention in affected communities.